Corcept Therapeutics Incorporated (CORT)
Interest coverage
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 107,282 | 112,634 | 124,477 | 128,202 | 111,606 |
| Interest expense | US$ in thousands | — | 3,557 | 3,596 | 5,637 | 5,070 |
| Interest coverage | — | 31.67 | 34.62 | 22.74 | 22.01 |
December 31, 2023 calculation
Interest coverage = EBIT ÷ Interest expense
= $107,282K ÷ $—K
= —
As the table does not provide the specific values for interest coverage for Corcept Therapeutics Inc across the years 2019 to 2023, it is difficult to analyze the trend and assess the company's ability to cover its interest obligations. It is essential to have the actual numerical data for interest coverage in order to evaluate the company's financial health and its capacity to meet interest payments from its operating income. I recommend obtaining the exact figures for interest coverage to conduct a meaningful analysis and gain insights into Corcept Therapeutics Inc's financial leverage and risk management.
Peer comparison
Dec 31, 2023